TGFB1 and renal fibrosis: The TGF-β1/Smad pathway is considered one of the most classical fibrotic signaling pathways and also plays a key role in the progression of renal fibrosis, which was identified by researchers as a therapeutic target for renal fibrosis back in the 1990s [16].